ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 50 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 20 au human albumin 200 g/l (20% w/v) 50 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 10 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; sodium chloride; water for injections - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 500 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 5 au human albumin 50 g/l (5% w/v) 500 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 25 g - injection, intravenous infusion - excipient ingredients: water for injections; sodium acetyltryptophanate; sodium chloride; sodium octanoate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 5 au human albumin 50 g/l (5% w/v) 250 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; water for injections; sodium chloride - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUMIN HUMAN 200G/L 200 g/l Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

albumin human 200g/l 200 g/l solution for infusion

octapharma limited - albumin human - solution for infusion - 200 g/l

ALBUMIN HUMAN 50G/L 50 g/l Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

albumin human 50g/l 50 g/l solution for infusion

octapharma limited - albumin human - solution for infusion - 50 g/l

DRAXIMAGE MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated Injection Australia - English - Department of Health (Therapeutic Goods Administration)

draximage maa kit for the preparation of technetium tc 99m albumin aggregated injection

global medical solutions australia pty limited t/a radpharm scientific - aggregated albumin, quantity: 2.5 mg; stannous chloride dihydrate, quantity: 0.1 mg; sodium chloride, quantity: 1.2 mg; albumin, quantity: 5 mg - powder - excipient ingredients: nitrogen; water for injections - technetium tc 99m albumin aggregated injection is a lung imaging agent which may be used as an adjunct in the evaluation of pulmonary perfusion in adults and paediatric patients. technetium tc 99m albumin aggregated injection may be used in adults as an imaging agent to aid in the evaluation of peritoneovenous (leveen) shunt patency.

FLEXBUMIN- albumin human injection, solution United States - English - NLM (National Library of Medicine)

flexbumin- albumin human injection, solution

takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.05 g in 1 ml - flexbumin 5% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia and cardiopulmonary bypass surgery. flexbumin 5% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 25% albumin should be used.4,6 flexbumin 5% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 5% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 5% is indicated in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace protein loss which accompanies any severe burn.4,6 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass surgery. flexbumin 5% is indicated a

FLEXBUMIN- albumin human solution United States - English - NLM (National Library of Medicine)

flexbumin- albumin human solution

takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.20 g in 1 ml - flexbumin 20% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (hdn). flexbumin 20% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% albumin should be used.4,6 flexbumin 20% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 20% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 20% is indicated, in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace the protein loss which accompanies any severe burn.4,6 adult respiratory distress syndrome (ards) flexbumin 20% is indicated, in conjunctio

Human Albumin Baxalta 50g/l, 500ml vial Malta - English - Medicines Authority

human albumin baxalta 50g/l, 500ml vial

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - albumin, human - solution for infusion - albumin, human 50 g/l - blood substitutes and perfusion solutions

ALBUMEX 4 albumin (human) 10g/250mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

albumex 4 albumin (human) 10g/250ml injection vial

csl behring australia pty ltd - albumin, quantity: 40 g/l - injection, solution - excipient ingredients: chloride; water for injections; sodium; octanoate - indications as at 27 january 2000 : hypovolaemia/shock: preservation of an adequate circulating blood volume should be the primary aim of therapy. the initial resuscitating fluid should not be a human blood product, but rather an alternative plasma volume expander should be used as a first-line replacement. albumex 4 may, however, be the initial plasma expander of choice if shock is associated with significant hypoalbuminaemia (albumin concentration less than 25g/litre), or if it is clinically desirable to avoid the infusion of large volumes of crystalloid solutions. albumex 4 may also be useful following initial resuscitation with crystalloid or synthetic colloid solutions in patients in whom extended support of the intravascular volume is required, such as seriously ill patients with multiple organ failure or the systemic capillary leak syndrome. cardiopulmonary bypass: albumex 4 may be used for priming the pump for cardiopulmonary bypass surgery for patients with poor left ventricular function, and other c